[go: up one dir, main page]

DE69518415D1 - Arznei für rheumatoide arthritis - Google Patents

Arznei für rheumatoide arthritis

Info

Publication number
DE69518415D1
DE69518415D1 DE69518415T DE69518415T DE69518415D1 DE 69518415 D1 DE69518415 D1 DE 69518415D1 DE 69518415 T DE69518415 T DE 69518415T DE 69518415 T DE69518415 T DE 69518415T DE 69518415 D1 DE69518415 D1 DE 69518415D1
Authority
DE
Germany
Prior art keywords
rheumatoid arthritis
medicine
remedy
monoclonal antibody
antibody recognizing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69518415T
Other languages
English (en)
Other versions
DE69518415T2 (de
Inventor
Tadashi Nishida
Sachiko Miyake
Hideo Yagita
Ko Okumura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo Nobel NV
Original Assignee
Kanebo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kanebo Ltd filed Critical Kanebo Ltd
Application granted granted Critical
Publication of DE69518415D1 publication Critical patent/DE69518415D1/de
Publication of DE69518415T2 publication Critical patent/DE69518415T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • C07K16/2845—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta2-subunit-containing molecules, e.g. CD11, CD18
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2821—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against ICAM molecules, e.g. CD50, CD54, CD102
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • C07K16/2842—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta1-subunit-containing molecules, e.g. CD29, CD49
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2875—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF/TNF superfamily, e.g. CD70, CD95L, CD153, CD154
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69518415T 1994-04-26 1995-03-22 Arznei für rheumatoide arthritis Expired - Fee Related DE69518415T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP8825194 1994-04-26
PCT/JP1995/000527 WO1995028961A1 (fr) 1994-04-26 1995-03-22 Medicament pour polyarthrite rhumatoide

Publications (2)

Publication Number Publication Date
DE69518415D1 true DE69518415D1 (de) 2000-09-21
DE69518415T2 DE69518415T2 (de) 2001-01-25

Family

ID=13937651

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69518415T Expired - Fee Related DE69518415T2 (de) 1994-04-26 1995-03-22 Arznei für rheumatoide arthritis

Country Status (9)

Country Link
US (1) US5855888A (de)
EP (1) EP0759302B1 (de)
AT (1) ATE195428T1 (de)
DE (1) DE69518415T2 (de)
DK (1) DK0759302T3 (de)
ES (1) ES2151054T3 (de)
GR (1) GR3034200T3 (de)
PT (1) PT759302E (de)
WO (1) WO1995028961A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1305100A (en) * 1998-10-07 2000-04-26 Karolinska Innovations Ab Anti-inflammatory alpha2, beta1 integrin-related substances or antibodies
WO2000064474A1 (en) * 1999-04-22 2000-11-02 Biogen, Inc. Method for the treatment of fibrosis using an antagonist of the integrin alpha-4 subunit
EA011384B1 (ru) 1999-06-01 2009-02-27 Байоджен Айдек Ма Инк. Способ лечения воспалительного заболевания
US6146639A (en) * 1999-07-26 2000-11-14 Merich Nick Arthritis, muscle pain, and dry skin remedy
DE60236735D1 (de) * 2001-04-13 2010-07-29 Biogen Idec Inc Antikörper gegen vla-1
US20030013107A1 (en) * 2001-06-07 2003-01-16 Rigel Pharmaceuticals, Incorporated Alpha 2 integrin: modulators of lymphocyte activation
EP1948798B1 (de) * 2005-11-18 2015-04-01 Glenmark Pharmaceuticals S.A. Anti-alpha2-integrin-antikörper und deren verwendungen
PL2034830T3 (pl) * 2006-05-25 2015-04-30 Biogen Ma Inc Przeciwciało anty-VLA-1 do leczenia udaru
US20080267978A1 (en) * 2006-08-28 2008-10-30 Mary Zutter Anti-angiogenic targets for cancer therapy
CA2840175C (en) 2011-05-19 2021-11-16 The Regents Of The University Of Michigan Integrin alpha-2 binding agents and use thereof to inhibit cancer cell proliferation
AU2013221635B2 (en) 2012-02-16 2017-12-07 Santarus, Inc. Anti-VLA1 (CD49a) antibody pharmaceutical compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0330506A3 (de) * 1988-02-26 1990-06-20 Dana Farber Cancer Institute VLA-Proteine
DK162890D0 (da) * 1990-07-06 1990-07-06 Novo Nordisk As Polypeptid
EP1266965B1 (de) * 1991-07-25 2006-05-24 Biogen Idec Inc. Rekombinante Antikörper zur humanen Therapie

Also Published As

Publication number Publication date
EP0759302A4 (de) 1997-11-19
DE69518415T2 (de) 2001-01-25
PT759302E (pt) 2001-01-31
EP0759302A1 (de) 1997-02-26
DK0759302T3 (da) 2000-11-13
ES2151054T3 (es) 2000-12-16
EP0759302B1 (de) 2000-08-16
US5855888A (en) 1999-01-05
ATE195428T1 (de) 2000-09-15
WO1995028961A1 (fr) 1995-11-02
GR3034200T3 (en) 2000-11-30

Similar Documents

Publication Publication Date Title
DE69518415D1 (de) Arznei für rheumatoide arthritis
ITMI921522A0 (it) Apparato di lavaggio e sterilizzazione di tappi di gomma, o simili impiegabili in confezioni farmaceutiche
ATE138569T1 (de) Topisch anzuwendendes arzneimittel enthaltend ketoprofenlysinat
DE69530316D1 (de) Antithrombose mittel und gegen den von willebrand-faktor gerichtete monoklonale antikörper
BR9607414A (pt) Utilizaçao de aerogéis inorgânicos em farmacologia
ATE312909T1 (de) Diagnostika und behandlungen von peridontalen erkrankungen
FI893159A (fi) Laite ja menetelmä terveydenhuollossa syntyvien ongelmajätteiden käsittelemiseksi
FR2656214B1 (fr) Cadre dynamique d'osteosynthese du rachis.
ATE314068T1 (de) Behandlung von seborrhoischer dermatitis
DE59410461D1 (de) Parasympathikomimetikum und parasympathikolytikum enthaltendes tts
MX9101958A (es) Inhibidores de acat de urea de aminosulfonilo
TR199801298T2 (xx) ACE-engelleyicinin dispeptik semptomlar�n tedavisinde yeni t�bbi kullan�m�.
FR2735132B1 (fr) Medicament polypeptidique modifie, composition et dispositif d'administration par electrotransport le contenant
ATE201828T1 (de) Verwendung eines cgrp antagonisten zur behandlung von flechten und pruritus und so erhaltene zubereitung
ES2133304T3 (es) Composiciones oftalmicas que comprenden combinaciones de un inhibidor de la anhidrasa carbonica y un antagonista beta-adrenergico.
DK0471718T3 (da) Paracetamolholdigt farmaceutisk præparat
ITRM910545A0 (it) Dispositivo trasportatore di bobine, rocche di filo e simili
ES2187618T3 (es) Utilizacion de compuestos de urea y de tiourea para la eliminacion o desintoxicacion de superantigenos de fluidos corporales.
ATE195055T1 (de) Insektizide zusammensetzung die diatomeenerde und siliziumdioxid enthalten
ATE107165T1 (de) Verwendung von macrolactonen als antiallergica.
RU94032792A (ru) Применение 5нтiа - антагонистов для прекращения использования табака
KR910700263A (ko) 시클로리노펩티드를 포함하는 의약
IT8819650A0 (it) Apparecchio per la ginnastica attiva del viso e del collo.
KR950701812A (ko) 렌티바이러스-유도된 질환의 치료에 유용한 생물학적으로 활성인 우레이도 유도체(Biologically active ureido dervatives useful in the treatment of lentivirus-induced sisease)
DE69431187D1 (de) 14-substituierte marcfortine und derivate als antiparasitäre mittel

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: AKZO NOBEL N.V., ARNHEIM/ARNHEM, NL

8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee